Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain

Brain Research

Volumn 799, Issue 1, 1998, Pages 78-83

  Kokoshka, Jerry M ^a   Metzger, Ryan R ^a   Wilkins, Diana G ^a   Gibb, James W ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Glutamate; Methamphetamine; Serotonin; Striatum; Transporter

Indexed keywords

GLUTAMIC ACID; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CARRIER PROTEINS; CORPUS STRIATUM; GLUTAMIC ACID; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMES; TIME FACTORS; XANTHINE OXIDASE;

EID: 0032514174     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00472-7     Document Type: Article

References (24)

1. Berman B.S., Hastings G.T. Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J. Neurochem. 69:1997;1185-1195.
2. Berman B.S., Zigmond J.M., Hastings G.T. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67:1996;593-600.
3. Boja J.W., McNeil R.M., Lewin A.H., Abraham P., Carroll F.I., Kuhar M.J. Selective dopamine transport inhibition by cocaine analogs. Neuroreport. 3:1992;984-986.
4. Borowsky B., Hoffman B.J. Neurotransmitter transporters: molecular biology, function, and regulation. Int. Rev. Neurobiol. 38:1995;139-158.
5. Commins D.L., Axt K.J., Vosmer G., Seiden L.S. 5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain. Brain Res. 403:1987;7-14.
6. Fleckenstein A.E., Metzger R.R., Beyler M.L., Gibb J.W., Hanson G.R. Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharm. 334:1997;111-114.
7. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282:1997;834-838.
8. Fleckenstein A.E., Wilkins D.G., Gibb J.W., Hanson G.R. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Ther. 283:1997;281-285.
9. Giovanni A., Liang P.L., Hastings G.T., Zigmond J.M. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64:1995;1819-1825.
10. Graham D.G., Tiffany S.M., Bell W.R. Jr., Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharm. 14:1978;644-653.
11. Gundersen V., Ottersen P.O., Storm-Mathisen J. Selective excitatory amino acid uptake in glutamatergic nerve terminals and in glia in the rat striatum: quantitative electron microscopic immunocytochemistry of exogenous D-aspartate and endogenous glutamate and GABA. Eur. J. Neurosci. 8:1996;758-765.
12. Hirata H., Ladenheim B., Rothman R.B., Epstein C., Cadet J.L. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677:1995;345-347.
13. Hotchkiss J.A., Gibb J.W. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214:1980;257-262.
14. Kondo T., Ito T., Sugita Y. Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Ann. N.Y. Acad. Sci. 738:1994;222-229.
15. Lesch K.P., Heils A., Riederer P. The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes. J. Mol. Med. 74:1996;365-378.
16. G.A. McPherson, EBDA-Ligand-Kinetic-Lowry, Elsevier-Biosoft, Cambridge, UK, 1986.
17. 2+-mediated binding of serotonin and dopamine to skeletal muscles actin: resemblance to serotonin binding proteins. Eur. J. Pharm. 288:1995;209-218.
18. Ramassamy C., Girbe F., Christen Y., Costentin J. Peroxidation of synaptosomes alters the dopamine uptake complex but spares the exocytotic release of dopamine. Neurodegeneration. 4:1995;155-160.
19. Schmidt C.J., Gibb J.W. Role of the serotonin uptake carrier in the neurochemical response to methamphetamine: effects of citalopram and chlorimipramine. Neurochem. Res. 10:1985;637-648.
20. Stone D.M., Johnson M., Hanson G.R., Gibb J.W. Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites. Eur. J. Pharmacol. 172:1989;93-97.
21. Swan N. Response to escalating methamphetamine abuse builds on NIDA-funded research. NIDA notes. 11:1996;19.
22. Usdin B.T., Mezey E., Chen C., Brownstein J.M., Hoffman J.B. Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. USA. 88:1991;11168-11171.
23. Volterra A., Trotti D., Tromba C., Floridi S., Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14:1994;2924-2932.
24. Zhang F., Dryhurst G. Oxidation chemistry of dopamine: possible insights into the age-dependent loss of dopaminergic nigrostriatal neurons. Bioorg. Chem. 21:1993;392-410.